[Hepatocellular carcinoma: Increase in incidence or future plague?]

Abstract:

:Hepatocellular carcinoma is the third most frequent cause of cancer death worldwide, particularly in Asia and Africa. Most cases complicate an underlying liver cirrhosis due to hepatitis B or C chronic virus infection or alcoholic abuse. But, following the current epidemics of obesity and type 2 diabetes, it appears that these diseases, associated in metabolic syndrome, are responsible for non alcoholic fatty liver disease at risk of HCC frequently before the stage of cirrhosis. Recent hypotheses consider that in the near future, cancer deaths due to HCC will overpass in USA those due to breast or colorectal cancers. Governments should develop policies to prevent obesity, type 2 diabetes and the metabolic syndrome as well as fight against alcoholism and hepatitis B and C virus infections.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Raoul JL,Raimbourg J,Hiret S,Adhoute X,Senellart H

doi

10.1016/j.bulcan.2018.02.003

subject

Has Abstract

pub_date

2018-05-01 00:00:00

pages

502-507

issue

5

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(18)30076-6

journal_volume

105

pub_type

杂志文章,评审
  • [Carcinoembryonic antigen in carcinoma of the uterine cervix (author's transl)].

    abstract::The authors analyse 123 cases of carcinoma of the uterine cervix treated by radiotherapy, with CEA radio-immuno-assay performed before treatment then each time patients are seen in follow-up. The CEA level is positive in 35 per cent of the cases with a mean value of 21 per cent for stage I, 36 per cent for stage II an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bolla M,Vrousos C,Horiot JC,Bordes M,Le Dorze C

    更新日期:1979-01-01 00:00:00

  • [Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region].

    abstract::Oncotype DX® has been validated as quantifying the likelihood of distant recurrence at 10 years and overall chemotherapy benefit in patients with estrogen-receptor-positive and HER-2-negative early breast cancer. In 2012, this genomic signature was routinely available for patients in Franche-Comté, France. Patients el...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1923

    authors: Nerich V,Curtit E,Bazan F,Montcuquet P,Villanueva C,Chaigneau L,Cals L,Méneveau N,Dobi E,Altmotlak H,Algros MP,Choulot MJ,Nallet G,Limat S,Mansion S,Pivot X

    更新日期:2014-07-01 00:00:00

  • [Marital communication and depressive symptoms in couples in which the woman has cancer of the breast].

    abstract::If doctor-patient communication is a frequent subject of research, couples communication where one partner has cancer is quite recent. Some studies deal with couples communication, but from an anecdotic perspective, without any operational measure. The aim of this paper is to study couples' communication frequency and...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Normand J,Lasry JC,Margolese RG,Perry JC,Fleiszer D

    更新日期:2004-02-01 00:00:00

  • Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.

    abstract:OBJECTIVE:The purpose of this study was to explore the risk factors that were associated with central lymph node metastasis (CLNM) in patients with clinical nodal negative differentiated thyroid carcinoma (cN0 DTC) after prophylactic central neck dissection (pCND). The influence of pCND on TNM staging and recurrence ri...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.04.003

    authors: Lin X,Chen X,Jiru Y,Du J,Zhao G,Wu Z

    更新日期:2016-06-01 00:00:00

  • [The frequency of cancer in France in year 2002, and trends since 1968].

    abstract::The estimated number of cancers diagnosed in 2002 is 150,000 in the male population and 120,000 in the female population and there were close to 88,000 cancer deaths among men and 59,000 cancer deaths among women in France. The most frequent cancer sites in the male population are prostate, lung, colon, intestine and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill C,Doyon F

    更新日期:2006-01-01 00:00:00

  • [PNET/Ewing tumours: current treatments and future perspectives].

    abstract::Ewing tumours are characterised as tumours consisting of small, blue, round malignant cells that may exhibit varying degrees of neural differentiation. Most of them arise in bony sites, and they represent the second commonest primary osseous malignancy in and adolescence and young adults. During the past 30 years, che...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1120

    authors: Marec-Bérard P,Chotel F,Claude L

    更新日期:2010-06-01 00:00:00

  • [Tumor-stroma interactions].

    abstract::It is widely accepted that the development of carcinoma is not only due to somatic mutations in epithelial cells but also is influenced by the tumor microenvironment ie the stroma. The different stroma components produced growth factors, cytokines, the extra cellular matrix and also participated to the recruitment of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0560

    authors: Billottet C,Jouanneau J

    更新日期:2008-01-01 00:00:00

  • [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation (allo-HCT) is a potentially curative option, in particular in the case of relapse after autologous stem cell transp...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2017.08.008

    authors: Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

    更新日期:2017-12-01 00:00:00

  • [Standards, Options and Recommendations for non metastatic breast cancer patients].

    abstract:CONTEXT:The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of French Cancer Centers (FNCLCC), the 20 French Cancer Centers, and specialists from French Public Universities, General Hospitals and Private Clinics. The main objective is the development of...

    journal_title:Bulletin du cancer

    pub_type: 指南,杂志文章,实务指引

    doi:

    authors: Mauriac L

    更新日期:2002-02-01 00:00:00

  • C cell hyperplasia.

    abstract::The evidence that C cell hyperplasia is the precursor of medullary carcinoma in families where this tumour is inherited is very strong. It is suggested that the tumour is the result of at least two mutations, in the families with medullary carcinoma the first of these is genetically determined, and the second is an ac...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Williams ED

    更新日期:1984-01-01 00:00:00

  • [Translation and validation of Brief Edinburgh Depression Scale (BEDS) in French].

    abstract:BACKGROUND:Depression is an important symptom for many palliative care patients but is rarely identified. It's known to reduce quality of life and impact on palliation of physical symptom. These physical symptoms can be improved by an adequate treatment of depression. Many depressed cancer patients are not treated due ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1310

    authors: Rhondali W,Perceau E,Saltel P,Girard R,Filbet M

    更新日期:2011-02-01 00:00:00

  • [Pulmonary malt lymphoma].

    abstract::This review will describe the current knowledge in the pathophysiology, diagnosis, prognosis and treatment of pulmonary MALT (Mucosa Associated Lymphoid Tissue) lymphoma. Pulmonary MALT lymphomas are low-grade B cell lymphoma and are the most frequent lymphomas arising from the lung. Tumour cells arise from mucosa ass...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1885

    authors: Borie R,Antoine M,Cadranel J,Wislez M

    更新日期:2014-02-01 00:00:00

  • [The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968].

    abstract::In 2003, there was 147,000 deaths attributed to cancer in France, 88,000 in men and 59,000 in women. Cancer mortality rates have been decreasing since 1987 in the male population and since the late 60's in the female population, the decrease is larger for the male population. This decrease is observed for most sites o...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill C,Doyon F

    更新日期:2007-01-01 00:00:00

  • [2 malignant cell lines derived from strain L6 of rat myogenic cells].

    abstract::A nonfusing variant M4 of the L6 line of rat myoblasts was isolated. This subline was tumorigenic when inoculated into suckling rats. Comparative studies of cells growth in vitro, serum requirement, cell adhesiveness and capacity to form colonies in soft agar confirmed that M4 cells had undergone neoplastic transforma...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hillion J,Leibovitch MP,Leibovitch SA,Harel J

    更新日期:1982-01-01 00:00:00

  • [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].

    abstract::Seventy-five patients with locally advanced non small cell lung carcinoma were entered in a phase II study combining chemotherapy (vindesine, lomustine, cisplatin and cyclophosphamide) and radical thoracic radiotherapy delivering a total dose of 60-65 Gy. Patients were regularly assessed by radiological and fiberoptic...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Nasr E,Pellae-Cosset B,Arriagada R,Le Chevalier T,Baldeyrou P,Ruffie P,de Cremoux H,Martin M,Tarayre M

    更新日期:1992-01-01 00:00:00

  • [10-year retrospective analysis of the sequelae of loco-regional treatment of breast cancer].

    abstract::With a minimum follow-up period of 10 years, the incidence of sequelae after loco-regional treatment of 349 breast cancers remains low, being dominated by lymphoedema. Rare after treatment by irradiation alone, lymphoedema appears more frequently in patients treated by radio-surgical association, in spite of a moderat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Calitchi E,Cheula JM,Otmezguine Y,Roucayrol AM,Mazeron JJ,Le Bourgeois JP,Pierquin B

    更新日期:1984-01-01 00:00:00

  • [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

    abstract::The antiestrogen tamoxifen (TAM) has been successfully used to treat breast cancer expressing estrogen and progesterone receptors (ER+ and PR+). However, the development of antiestrogen resistance is frequently observed in patients following long-term treatment. To better understand the mechanism of action of TAM and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachmann-Moisson N,Barberi-Heyob M,Merlin JL,Ledrich ML,Batt AM,Guillemin F

    更新日期:1996-10-01 00:00:00

  • Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.

    abstract::To show the nature and magnitude of EKG anomalies subsequent to 5-fluorouracil (5FU) administration and determine whether the onset is dependent on a pre-existing cardiovascular pathological condition. 1,350 patients were treated by 5FU between 1995 and 2000. EKG were recorded in all patients before each administratio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tsibiribi P,Descotes J,Lombard-Bohas C,Barel C,Bui-Xuan B,Belkhiria M,Tabib A,Timour Q

    更新日期:2006-03-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • [Breast cancer screening: On our way to the future].

    abstract::Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important improvements in prognosis over the past 20 years, breast cancer scree...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2016.06.005

    authors: Delaloge S,Bachelot T,Bidard FC,Espie M,Brain E,Bonnefoi H,Gligorov J,Dalenc F,Hardy-Bessard AC,Azria D,Jacquin JP,Lemonnier J,Jacot W,Goncalves A,Coutant C,Ganem G,Petit T,Penault-Llorca F,Debled M,Campone M,Levy

    更新日期:2016-09-01 00:00:00

  • [Treatment of metastatic kidney neoplasms with a new interleukin 2 protocol: The experience of the Gustave-Roussy Institute].

    abstract::Treatment of metastatic renal cell carcinoma with interleukin 2 (IL2) remains controversial despite the authorization from the French government for IL2 with the West schedule in this disease. We report herein the study of the Institute Gustave-Roussy of 73 patients, who received from 1989 to 1991 a new schedule of hi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Escudier B,Farace F,Théodore C,Angevin E,Court B,Couanet D,Dietrich PY,Culine S,Pallardy M,Hercend T

    更新日期:1995-04-01 00:00:00

  • [IMiDs in hematology].

    abstract::IMiDs belong to a new pharmalogical class, whose principal therapeutic agents are the thalidomide and the lenalidomide. They have immunomodulatory and antiangiogenic properties, as well as a direct effect on tumor cells. Thalidomide and lenalidomide were first approved for multiple myeloma, and in 5q-myelodysplastic s...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1404

    authors: Wémeau M,Gauthier J,Leleu X,Yakoub-Agha I

    更新日期:2011-08-01 00:00:00

  • [Clinical development of anti-angiogenic agents in 2002].

    abstract::In 2002, new developments in anti-angiogenic strategies encompassed two main aspects. Firstly, essential improvements were made in the field of methodology : novel techniques permitted to measure directly on patients the biological effects induced by anti-angiogenic treatments in the course of clinical trials. Secondl...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachelot T,Jouanneau E,Blay JY

    更新日期:2003-01-01 00:00:00

  • [Rational choice of a diagnostic test for the detection of bone metastases in breast cancer as a function of prevalence (based on the Bayes theorem)].

    abstract::Since 1976 to 1978 inclusive, 465 patients with primary breast cancers underwent whole body analogical scintiscans, 456 numerical scans, and 453 were X-rayed. Ninety per cent received axillary node ablation, 62% presented adenopathies of which a third were capsular ruptures and 54% were T3 and T4. In 53 patients, the ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Robillard J,Ly Van Hoa,Switzers O,Couette JE,Brune D

    更新日期:1987-01-01 00:00:00

  • [Treatment of mucositis pain: News and prospects].

    abstract::Mucositis, an acute inflammation of the digestive mucosa, is one of the main toxicities secondary to oncological treatments. Among its consequences, mucositis-related pain is an important complication due to its intensity and repercussion, especially on quality of life. Treatment of pain plays a central role in manage...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2019.03.022

    authors: Guerrini-Rousseau L,Marec-Berard P,Bolle S,Laurent S

    更新日期:2019-09-01 00:00:00

  • [BCG therapy of superficial tumors of the bladder].

    abstract::Superficial bladder tumor defined as pTa, pT1 and pTis stage is one of the most common cancer disease in the world. Intravesical BCGtherapy represents the best treatment when combined with transurethral resection to prevent tumor recurrence or progression and to lengthen the interval between recurrence. The toxicity i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Prapotnich D

    更新日期:1998-02-01 00:00:00

  • [Major therapeutic advances in the treatment of metastatic melanoma].

    abstract::The treatment of metastatic melanoma is presently in complete revolution. Two molecules have recently been authorized for this indication. These treatments have a very different mechanism of action compared to previous chemotherapies. Vemurafenib is a targeted therapy, which blocks BRAF selectively. This molecule indu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1594

    authors: Mateus C,Robert C

    更新日期:2012-06-01 00:00:00

  • [Urinary incontinence and sexual dysfunction after treatment of localized prostate cancer: Results from a population aged less than 65years old].

    abstract:INTRODUCTION:An increasing number of patients with prostate cancer (PC) are diagnosed and treated. The aim of this study was to investigate urinary incontinence (UI) and sexual dysfunction (SD) two years after treatment for localized prostate cancer (PC). METHODS:This study followed all cases of localized PC diagnosed...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.09.011

    authors: Bessaoud F,Orsini M,Iborra F,Rebillard X,Faix A,Soulier M,Daurès JP,Trétarre B

    更新日期:2016-10-01 00:00:00

  • [Li-Fraumeni syndrome].

    abstract::The Li-Fraumeni syndrome is an autosomal dominant syndrome representing a genetic predisposition to a wide spectrum of tumours including sarcomas, breast carcinomas, brain tumors and adrenocortical carcinomas. In most of the cases, tumours will develop in children and young adults. Germline mutations of the tumor supp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frebourg T

    更新日期:1997-07-01 00:00:00

  • [The impact of gynaecological cancers on woman's sexuality and her couple].

    abstract::This article, devoted specifically to gynaecological cancers and their impact on the sexual and marital lives, is a collaboration between the psychologists and onco-gynaecologist within a cancer center. In oncology, gynaecological cancers' treatments involve at the same time anatomical, physiological and functional mo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.02.008

    authors: Vanlerenberghe E,Sedda AL,Ait-Kaci F

    更新日期:2015-05-01 00:00:00